Rite Aid Reports 1.9 Percent Same Store Sales Increase for July
July 28 2011 - 8:30AM
Business Wire
Rite Aid Corporation (NYSE: RAD) today announced sales results
for July.
Monthly Sales
For the four weeks ended July 23, 2011, same store sales
increased 1.9 percent over the prior-year period. July front-end
same store sales increased 3.1 percent while pharmacy same store
sales, which included an approximate 151 basis points negative
impact from new generic introductions, increased 1.4 percent.
Prescription count at comparable stores decreased 0.4 percent over
the prior-year period.
Total drugstore sales for the four-week period increased 1.6
percent to $1.916 billion compared to $1.886 billion for the same
period last year. Prescription revenue accounted for 67.6 percent
of drugstore sales, and third party prescription revenue
represented 96.5 percent of pharmacy sales.
Year-to-Date Sales
Same store sales for the 21-week period ended July 23, 2011
increased 1.2 percent, consisting of a 0.9 percent front-end same
store sales increase and a 1.3 percent increase in pharmacy same
store sales. Prescriptions filled at comparable stores increased
0.3 percent over the prior-year period.
Total drugstore sales for the 21 weeks ended July 23, 2011
increased 0.5 percent to $10.210 billion from $10.163 billion in
last year’s like period. Prescription revenue accounted for 68.3
percent of total drugstore sales, and third-party prescription
revenue was 96.5 percent of pharmacy sales.
Rite Aid is one of the nation’s largest drugstore chains. On
July 23, 2011, the company operated 4,702 stores compared to 4,751
stores in the like period a year ago. Information about Rite Aid,
including corporate background and press releases, is available
through the company’s website at http://www.riteaid.com. Note that
all sales data in this release is preliminary, unaudited and
subject to revision.
Statements in this release that are not historical are
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are not guarantees of future
performance and involve risks, assumptions and uncertainties that
are described in Item 1A (Risk Factors) of our most recent Annual
Report on Form 10-K and in other documents that we file or furnish
with the Securities and Exchange Commission, which you are
encouraged to read. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially from those indicated
or anticipated by such forward-looking statements. Accordingly, you
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date they are made. Rite Aid
expressly disclaims any current intention to update publicly any
forward-looking statement after the distribution of this release,
whether as a result of new information, future events, changes in
assumptions or otherwise.
Rite Aid (NYSE:RAD)
Historical Stock Chart
From Apr 2024 to May 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
From May 2023 to May 2024